Investigation on the Role of ROS in Integrin-Mediated Signaling of Progressive Glomerulonephritis
Investigation on the Role of ROS in Integrin-Mediated Signaling of Progressive Glomerulonephritis
批准号:
18591189
负责人:
KAGAMI Shoji
金额:
$2.36万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In order to clarify the role of ROS in the integrin-dependent signaling involved in progressive glomerulonephritis (GN), we investigated the localization and function of NAD(P)H oxidase -derived ROS signaling using a model of experimental GN (WKY masugi GN) and cultured parietal epithelial cells(PEC). Glomerular and crescent expression of NAD(P)H and DHE was increased in parallel with PEC proliferation and matrix accumulation during the course of GN. Inhibition of ROS production with angiotensin receptor inhibitor (ARB) in this GN model revealed that NAD(P)H oxidase-derived ROS signaling play an important role in PEC proliferation, matrix remodeling and crescent formation in progressive GN. Immunofluorescent study with cultured PEC showed that other Nox proteins except Nox2 may play a role in NAD(P)H oxidase oxidase-derived ROS signaling seen in progressive GN and crescent formation. These results indicate that NAD(P)H oxidase-derived ROS signaling play a critical role in crescent formation in progressive GN. Further study is required for development of pharmacological tool to inhibit NAD(P)H oxidase-derived ROS signaling involved in progression of GN in human.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1007/s00467-008-0801-6
发表时间:
2008-08-01
期刊:
PEDIATRIC NEPHROLOGY
影响因子:
3
作者:
[Takamatsu, Masanori, Urushihara, Maki, Kagami, Shoji]
通讯作者:
Kagami, Shoji
腎炎進行に及ぼす細胞外基質の影響
细胞外基质对肾炎进展的影响
DOI:
--
发表时间:
2006
期刊:
医学の歩み 218・7.8
影响因子:
--
作者:
[Takamatsu, Masanori, et. al., 漆原 真樹, Izawa Yuki, 香美 祥二]
通讯作者:
香美 祥二
Up-regulation of integrin-linked kinase activity in rat mesangio-proliferative glomerulonephritis.
大鼠系膜增生性肾小球肾炎中整合素相关激酶活性的上调。
DOI:
--
发表时间:
2006
期刊:
Life Sci 78・16
影响因子:
--
作者:
[Takamatsu, Masanori, et. al., 漆原 真樹, Izawa Yuki, 香美 祥二, Shimizu Maki, Kondo Shuji, Kagami Shoji]
通讯作者:
Kagami Shoji
DOI:
10.1291/hypres.30.1107
发表时间:
2007-11
期刊:
Hypertension Research
影响因子:
5.4
作者:
[Yuki Izawa;M. Yoshizumi;K. Ishizawa;Y. Fujita;Shuji Kondo;S. Kagami;K. Kawazoe;K. Tsuchiya;S. Tomita;T. Tamaki]
通讯作者:
Yuki Izawa;M. Yoshizumi;K. Ishizawa;Y. Fujita;Shuji Kondo;S. Kagami;K. Kawazoe;K. Tsuchiya;S. Tomita;T. Tamaki
腎病態生理におけるERKシグナルの制御機構と役割
ERK信号在肾脏病理生理学中的控制机制和作用
DOI:
--
发表时间:
2007
期刊:
日本小児腎臓病学会雑誌 20
影响因子:
--
作者:
[Takamatsu, Masanori, et. al., 漆原 真樹]
通讯作者:
漆原 真樹
共 8 条
Role of ADAM17 in the progression of chronic kidney disease
-
批准号:17K10144
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2017
-
负责人:KAGAMI Shoji
-
依托单位:
Analyzing glomerular renin angiotensin system with peptidomics for development of therapeutic and diagnostic methods inhibiting disease progression of chronic kidney disease
-
批准号:26461614
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2014
-
负责人:KAGAMI Shoji
-
依托单位:
The role of angiopoietin-like protein 4 (ANGPTL4) in the glomerular endothelial cell injury and progressive glomerular injury
-
批准号:23591570
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2011
-
负责人:KAGAMI Shoji
-
依托单位:
The role of reactive oxygen species (ROS) in the progressive kidney disease in children, and therapeutic strategy based on its mechanisms.
-
批准号:20591278
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2008
-
负责人:KAGAMI Shoji
-
依托单位:
Investigation for the role of collagen-binding integrin receptor in the development of renal fibrosis
-
批准号:14570748
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:2002
-
负责人:KAGAMI Shoji
-
依托单位:
Investigation of Integrin-mediated MAP kinase Signaling in Glomerulonephritis
-
批准号:12670756
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:2000
-
负责人:KAGAMI Shoji
-
依托单位:
IDENTIFICATION OF NEW GLOMERULAR PROGRESSION FACTORS USING MONOCLONAL ANTIBODY
-
批准号:08670894
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1996
-
负责人:KAGAMI Shoji
-
依托单位:
国内基金
海外基金
登录
查看更多内容
血管衰老通过lumican-integrinα2β1通路诱导NVU调控认知障碍的分子机制及干预靶点研究
-
批准号:JCZRLH202602095
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
β1-integrin介导的Warburg效应在TAM耐药乳腺癌中的作用及机制
-
批准号:JCZRLH202600554
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
睡眠剥夺经TNN/Integrin α8β1轴调控巨噬细胞极化促动脉粥样硬化的作用及机制研究
-
批准号:2025JJ60778
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:高嘉慧
-
依托单位:
维生素D受体通过抑制Mucin-1/β1-integrin信号通路调节肠道衰老的相关机制研究
-
批准号:MS25H030029
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:余梦丽
-
依托单位:
Integrinβ7阳性肥大细胞诱导免疫抑制微环境促进胰腺癌进展机制和干预策略研究
-
批准号:QN25H030033
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:吴将超
-
依托单位:
低强度脉冲超声波通过调控integrin β1/ FAK/ MAPKs信号轴诱导巨噬细胞自噬治疗糖尿病足的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:郭恩琪
-
依托单位:
Osteopontin-Integrin-TAM-M2轴介导泌乳素细胞腺瘤耐药及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:汤浩
-
依托单位:
SMYD5 上调 EZH2-integrin β 1 通路促进三阴乳腺癌骨转
移的作用机制及其临床意义
-
批准号:2024JJ6590
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:丁诗容
-
依托单位:
Fndc5/irisin调控Integrin信号通路在乳腺癌溶骨性骨转移中的作用及
机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:刘扬
-
依托单位:
丝素蛋白膜拓扑结构通过Integrin-Yap通路诱导BMSCs成软骨分化促
软骨修复的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:王鑫
-
依托单位: